Valuation: Sysmex Corporation

Market Cap 1,101B 6.98B 6.2B 5.79B 5.27B 9.95B 671B 10.04B 70.03B 27.14B 343B 26.2B 25.63B P/E 2027 *
27.5x
P/E 2028 * 22.4x
Enterprise Value 1,122B 7.11B 6.32B 5.9B 5.38B 10.14B 684B 10.23B 71.37B 27.66B 349B 26.7B 26.12B EV / Sales 2027 *
2.04x
EV / Sales 2028 * 1.94x
Free-Float
71.34%
Yield 2027 *
2.22%
Yield 2028 * 2.31%
1 day-2.68%
1 week-4.34%
Current month-1.44%
1 month-3.55%
3 months+18.97%
6 months+27.17%
Current year+17.89%
1 week 1,816.5
Extreme 1816.5
1,917
1 month 1,737
Extreme 1737
1,939
Current year 1,246
Extreme 1246
2,012.5
1 year 1,246
Extreme 1246
2,012.5
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 77 2018-03-31
Director of Finance/CFO 56 -
President 65 2026-03-31
Director TitleAgeSince
Chairman 77 2013-03-31
Director/Board Member 65 2019-05-31
Director/Board Member 71 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.68%-4.34%+1.93%-23.00% 6.98B
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -0.49%-1.20%-9.66%+10.02% 69.72B
Weighted average by Cap. -0.00%-1.33%-16.88%+10.89%

Financials

2027 *2028 *
Net sales 548B 3.48B 3.09B 2.88B 2.63B 4.96B 334B 5B 34.9B 13.52B 171B 13.06B 12.77B 578B 3.66B 3.25B 3.04B 2.77B 5.22B 352B 5.27B 36.75B 14.24B 180B 13.75B 13.45B
Net income 40.29B 255M 227M 212M 193M 364M 24.56B 368M 2.56B 994M 12.56B 959M 938M 49.42B 313M 278M 260M 237M 447M 30.12B 451M 3.14B 1.22B 15.4B 1.18B 1.15B
Net Debt 21.08B 134M 119M 111M 101M 191M 12.85B 192M 1.34B 520M 6.57B 502M 491M 20.58B 130M 116M 108M 98.63M 186M 12.54B 188M 1.31B 507M 6.41B 490M 479M
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
26-10-02 JP¥1,818.50 -2.68% 2,715,600
26-10-01 JP¥1,868.50 +1.27% 2,715,300
26-09-30 JP¥1,845.00 -0.75% 3,423,200
26-09-29 JP¥1,859.00 -2.18% 2,656,900
26-09-28 JP¥1,900.50 -0.03% 3,083,600
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,818.50JPY
Average target price
2,121.43JPY
Spread / Average Target
+16.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock